Table 2. Correlation of TAZ expression with clinicopathological features of rectal cancer patients.
| Clinicopathological features | Non-RT | RT | ||||
| Weak (%) | Strong (%) | p-value | Weak (%) | Strong (%) | p-value | |
| Gender | ||||||
| Male | 13(30) | 30(70) | 0.617 | 23(58) | 17(42) | 0.905 |
| Female | 8(25) | 24(75) | 14(56) | 11(44) | ||
| Age (year) | ||||||
| ≤67 | 8(26) | 23(74) | 0.722 | 16(59) | 11(41) | 0.748 |
| >67 | 13(29) | 31(61) | 21(55) | 17(45) | ||
| TNM stage | ||||||
| I+II+III | 18(25) | 53(75) | 0.031 | 32(54) | 27(46) | 0.170 |
| IV | 3(75) | 1(25) | 5(83) | 1(17) | ||
| Differentiation | ||||||
| Well+Moderate | 15(24) | 47(76) | 0.108 | 29(58) | 21(42) | 0.748 |
| Poor | 6(46) | 7(54) | 8(53) | 7(47) | ||
| Mucinous | ||||||
| Negative | 13(21) | 48(79) | 0.004 | 29(57) | 22(43) | 0.854 |
| Positive | 7(64) | 4(36) | 6(60) | 4(40) | ||
Varied number in the different variables is due to missing data.